In the field of epidemiology, nanovaccines hold significant promise due to their potential to improve vaccine efficacy and coverage. This is crucial for controlling infectious diseases, especially in populations where traditional vaccines have limited effectiveness. Nanovaccines can be designed to elicit stronger and more durable immune responses, which is vital for achieving herd immunity.
